Atlas Trials

Exatecan Mesylate in Treating Children With Relapsed or Refractory Rhabdomyosarcoma

Clinical trial NCT00055939 · COMPLETED

Trial details

NCT number
NCT00055939
Sponsor
Daiichi Sankyo
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Sarcoma
Start date
2003-01-01
Primary completion
2006-04-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.